Increase in plasma viral load after oral cholera immunization of HIV-infected subjects

AIDS

Volumn 12, Issue 14, 1998, Pages

  Ortigão de Sampaio, Maria Beatriz ^a,c   Shattock, Robin J ^b   Hayes, Peter ^b   Griffin, George E ^b   Linhares de Carvalho, Maria Inêz ^c   Ponce De Leon, Antonio ^c   Lewis, David J M ^b   Castello Branco, Luiz Roberto R ^a,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

CD4; Gut associated lymphoid tissue; Immune activation; Natural history; Oral immunization; Progression; Viral load

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CHOLERA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BRAZIL; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VACCINATION; VIREMIA; VIRUS LOAD;

EID: 0032189090     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199814000-00001     Document Type: Article

References (22)

1. Zagury D, Bernard J, Leonard R: Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 1986, 231:850-853.
2. Bukrinsky M, Stanwick T, Dempsey M, Stevenson M: Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991, 254:423-427.
3. Shattock R, Burger D, Dayer J-M, Griffin GE: Enhanced HIV replication in monocytic cells following engagement of adhesion molecules and contact with stimulated T cells. Res Virol 1996, 147:171-179.
4. Donovan RM, Bush CM, Markowitz NP, Baxa DM, Saravolatz LD: Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis 1996, 174:401-403.
5. Bush CM, Donovan RM, Markowitz NP, Kvale P, Saravolatz LD: A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:23-26.
6. Staprans SI, Hamilton BL, Follansbee SE, et al.: Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995, 182:1727-1737.
7. Stanley SK, Ostrowski MA, Justement JS, et al.: Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type-1. N Engl J Med 1996, 334:1222-1230.
8. Cheeseman SH, Davaro RE, Ellison RT III: Hepatitis B vaccination and plasma HIV-1 RNA [letter]. N Engl J Med 1996, 334:1272.
9. Gilks CF: The clinical challenge of the HIV epidemic in the developing world. Lancet 1993, 342:1037-1039.
10. Pantaleo G, Grazosi C, Demarest JF, et al.: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-338.
11. Mowat AM, Viney JL: The anatomical basis of intestinal immunity. Immunol Rev 1997, 156:145-166.
12. Svennerholm A-M, Jertborn M, Gotheĺors L, Karim AM, Sack DA, Holmgren J: Mucosal antitoxic and antibacterial immunity after cholera disease and after immunisation with a combined B subunit-whole cell vaccine. J Infect Dis 1984, 149:884-893.
13. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H: The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10:75-88.
14. Hörnqvist E, Goldschmidt TJ, Holmdahl R, Lycke N: Host defence against cholera toxin is strongly CD4+ T cell dependent. Infect Immun 1991, 59:3630-3638.
15. Lewis DJM, Novotny P, Dougan C, Griffin GE: The early cellular and humoral immune response to primary and booster oral immunization with oral cholera toxin B subunit. Eur J Immunol 1991, 21:2087-2094.
16. Castello-Branco LRR, Griffin GE, Poulton TA, Dougan G, Lewis DJM: Characterization of the circulating T-cell response after oral immunization of human volunteers with cholera toxin B subunit. Vaccine 1994, 12:65-72.
17. Lewis DJM, Gilks CF, Ojoo S, et al.: Immune response following oral administration of cholera toxin B subunit to HIV-1-infected UK and Kenyan subjects. AIDS 1994, 8:779-785.
18. Castello-Branco LR, Linhares-de-Carvalho MI, Ponce de Leon AC: AIDS therapy in Brazil [letter]. Nature 1998, 392:431.
19. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-19.
20. Holmgren J, Svennerholm A-M, Gothefors L, Jertborn M, Stoll B: Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination. Infect Immun 1988, 56:230-233.
21. Kroon FP, van Furth R, Bruisten SM: The effects of immunization in human immunodeficiency virus type-1 infection. N Engl J Med 1996, 335:817-818.
22. Lim SG, Condez A, Lee CA, Johnson MA, Elias C, Poulter LW: Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993, 92:448-454.